Positron emission tomography for prostate, bladder, and renal cancer
Top Cited Papers
- 1 October 2004
- journal article
- review article
- Published by Elsevier BV in Seminars in Nuclear Medicine
- Vol. 34 (4), 274-292
- https://doi.org/10.1053/j.semnuclmed.2004.06.004
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 2003
- Prognostic Value of Bone Scan in Patients With Metastatic Prostate Cancer Treated Initially With Androgen Deprivation TherapyJournal of Urology, 2002
- Pulmonary metastases: can accurate radiological evaluation avoid thoracotomic approach?European Journal of Cardio-Thoracic Surgery, 2002
- CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMAJournal of Urology, 2001
- Differential Metabolism and Pharmacokinetics of ?-[1-11C]-Methionine and 2-[18F] Fluoro-2-deoxy-?-glucose (FDG) in Androgen Independent Prostate CancerClinical Positron Imaging, 1999
- FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY SCAN OF PROSTATE CANCER BONE METASTASES WITH FLARE REACTION AFTER ENDOCRINE THERAPYJournal of Urology, 1999
- Detection of bony metastases of androgen-independent prostate cancer by PET-FDGNuclear Medicine and Biology, 1996
- Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumour: comparison with final pathological stage in invasive bladder carcinomaBritish Journal of Urology, 1996
- Evaluation of the current incidence of nodal metastasis from prostate cancerJournal of Surgical Oncology, 1993